135 related articles for article (PubMed ID: 35012874)
1. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators of germline genetic evaluation for prostate cancer.
Loeb S; Li R; Sanchez Nolasco T; Byrne N; Cheng HH; Becker D; Leader AE; Giri VN
Prostate; 2021 Aug; 81(11):754-764. PubMed ID: 34057231
[TBL] [Abstract][Full Text] [Related]
3. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
[TBL] [Abstract][Full Text] [Related]
4. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
Loeb S; Giri VN
Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
[TBL] [Abstract][Full Text] [Related]
6. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
[TBL] [Abstract][Full Text] [Related]
7. Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation
Loeb S; Byrne N; Walter D; Makarov DV; Wise DR; Becker D; Giri VN
Cancer Treat Res Commun; 2020; 25():100212. PubMed ID: 33091732
[TBL] [Abstract][Full Text] [Related]
8. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
[TBL] [Abstract][Full Text] [Related]
9. What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
Greenberg S; Slager S; Neil BO; Cooney K; Maughan B; Stopa N; Venne V; Zickmund S; Colonna S
Prostate; 2020 Apr; 80(5):441-450. PubMed ID: 32027768
[TBL] [Abstract][Full Text] [Related]
10. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
[TBL] [Abstract][Full Text] [Related]
11. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
[TBL] [Abstract][Full Text] [Related]
12. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
Mark JR; McDougall C; Giri VN
Urol Clin North Am; 2021 Aug; 48(3):311-322. PubMed ID: 34210487
[TBL] [Abstract][Full Text] [Related]
13. Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
Dron HA; Bucio D; Young JL; Tabor HK; Cho MK
J Genet Couns; 2023 Feb; 32(1):166-181. PubMed ID: 36301246
[TBL] [Abstract][Full Text] [Related]
14. Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.
Birmingham WC; Agarwal N; Kohlmann W; Aspinwall LG; Wang M; Bishoff J; Dechet C; Kinney AY
BMC Health Serv Res; 2013 Jul; 13():279. PubMed ID: 23870420
[TBL] [Abstract][Full Text] [Related]
15. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
Gunn CM; Li EX; Gignac GA; Pankowska M; Loo S; Zayhowski K; Wang C
Cancer Control; 2023; 30():10732748221143884. PubMed ID: 36946278
[TBL] [Abstract][Full Text] [Related]
16. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
[TBL] [Abstract][Full Text] [Related]
17. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
[TBL] [Abstract][Full Text] [Related]
18. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
[TBL] [Abstract][Full Text] [Related]
19. Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.
Cremers R; van Asperen C; Kil P; Vasen H; Wiersma T; van Oort I; Kiemeney L
Fam Cancer; 2012 Jun; 11(2):195-200. PubMed ID: 22160565
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.
Bristow B; Aldehaim M; Bonin K; Lam CCK; Wan SJ; Cao X; Szumacher E
J Cancer Educ; 2018 Dec; 33(6):1195-1200. PubMed ID: 28573519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
